A collection of best practices in public health

The exploration and adoption of best practices in health by public institutions and non-governmental organizations as well has been growing in recent years. ASSET experts recognize the importance of these activities. Thus, they will gather examples from all around Europe and present them on a dedicated page.

But what exactly are “best practices”, and what are the differences between best and good practices?

Following the Business Dictionary, “A best practice is a method… that has consistently shown results superior to those achieved with other means, and that is used as a benchmark”. On the other hand, a good practice is a method that has shown results or preliminary results superior to those achieved with other means. In particular, as far as ASSET is concerned, good practice will refer to activities that are in alignment with issues that were previously identified by the project.

A key element of these practices will be the active involvement of civil society during their inception/design phase, the implementation phase or the evaluation phase. Projects that incorporate themes of Science-in-Society but where civil society is included with a passive role (such as analyses of social media posts or leaflet dissemination) and without impact on policies or communication strategies, are not to be considered as best/good practices of interest for the ASSET platform.

The search of good practices examples will be focused on some key themes:

  • Vaccination: trust rebuilding, trust monitoring, propensity to vaccinate
  • Non-pharmaceutical steps, such as decreasing behaviours at risk and/or increasing risk-reducing behaviours
  • Health care workers
  • Gender issues
  • Low income or ethnic minorities
  • Communication and PH decision and in particular two-way communication/decision in public health
  • Didactic Projects concerning the role of SiS in Pandemics and Epidemics

This is a non-exhaustive list and it will be updated all along the project

By doing so, ASSET experts purse the following general aims:

  • To communicate to the civil society the existence of practices of interest for ASSET. In particular, to seek out solutions that are already de facto best practices but have not yet been widely adopted.
  • To encourage, when possible, the participation of the civil society to ongoing practices.
  • To transfer knowledge of best practices among researchers, practitioners, institutions and organizations.

Note that the Best Practice Platform will be sided by a Stakeholder Portal, which will provide a gateway for interested stakeholders, organizations, institutions, universities and other relevant actors to register their interest in becoming involved in the discussion on these practices and on issues that needs the creation of new ones.

Finally, as result of the above considerations, and taking into the account the collected practices and feedback gathered in the Stakeholder Portal, a section of the Best Practice Platform will be devoted to the development of guide lines for the development of best practices.

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence